Compound ID | 765

AM-3005

Class: Pleuromutilin, Quinolone

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Protein synthesis inhibitor. Additionally a DNA synthesis inhibitor; bacterial topoisomerase inhibitor; topoisomerase II inhibitor
Target Pathogen: Active against methicillin-resistant Staphylococcus aureus
Description: A mutilin-quinolone hybrid antibiotic
Institute where first reported: Kyorin Pharamaceutical Co., Ltd., Japan
Year first mentioned: 2008
Development status: Experimental

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.